Assessment of Blood Viscosity in ARDS (Acute Respiratory Distress Syndrome)

NCT07823296 · tracked via the Priya Life Science France tracker

Sponsor

Hospices Civils de Lyon

Phase

Observational

Started

2026-10-01

Last updated

2026-09-16

Condition(s) studied

ARDS

Investigational drug(s) / intervention(s)

Blood draws (peripheral venous puncture)Blood draws (arterial catheter, central venous line, or Swan-Ganz catheter)

Blood draws (peripheral venous puncture): Procedure performed by intensive care nurses. Case group : Daily blood draws (4 mL) for 7 days. Control group : blood draws (4 mL) on Day 1.

Blood draws (arterial catheter, central venous line, or Swan-Ganz catheter): Case group : For patients with an arterial catheter, central venous line, or Swan-Ganz catheter, an additional blood sample will be collected on Day 1.

Study summary

Acute respiratory distress syndrome (ARDS) is characterized by damage to the alveolar-capillary membrane, resulting in hypoxemia, decreased pulmonary compliance, and hemodynamic changes.

Critical conditions (hypoxia; septic shock associated with ARDS) can alter blood viscosity. These changes in viscosity can affect blood flow and hemodynamics.

There is only one clinical study that has measured one of the determinants of blood viscosity in ARDS (deformability), even though other parameters are involved in viscosity (elongation, deformability, hematocrit, etc.), and it is possible to measure blood viscosity comprehensively. To date, therefore, no study has evaluated the various parameters of blood viscosity in ARDS.

The aim of this study is to investigate hyperviscosity in patients with ARDS and to assess whether this hyperviscosity correlates with respiratory or hemodynamic changes.

The investigators will therefore compare blood viscosity and its determinants in patients admitted to the intensive care unit for ARDS and in patients admitted for other reasons (excluding ARDS or sepsis/septic shock).

The investigators will also conduct a longitudinal assessment of changes in hemodynamic, respiratory, and viscosity parameters during ARDS

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Case Group Inclusion Criteria: * Age ≥ 18 ans * Moderate-to-severe ARDS according to the global definition: * with PaO₂/FiO₂ ≤ 200 mmHg (based on arterial blood gas analysis in patients receiving invasive or non-invasive mechanical ventilation or high-flow nasal oxygen therapy). * Participation agreement obtained (either from the patient themselves or from a relative) Exclusion Criteria: * ARDS that has been present for more than 72 hours * Terminally ill patient with death expected within 24 hours * Patient who has received a blood transfusion within the past month * Patient with a known hematologic malignancy (lymphoma; myeloma; acute or chronic leukemia) * Patient with a known hemoglobinopathy. * Hemorrhagic shock * Hemoglobin \< 70 g/dL Control group Inclusion Criteria: * Age ≥ 18 ans * Participation agreement obtained (either from the patient themselves or from a relative) Exclusion Criteria: * Presence of ARDS according to the global definition * P/F \< 300 mmHg * Presence of sepsis defined by an infection and a SOFA score delta ≥ 2. * Terminally ill patient with death expected within 24 hours * Patient who has received a blood transfusion within the past month * Patient with a known hematologic malignancy (lymphoma; myeloma; acute or chronic leukemia) * Patient with a known hemoglobinopathy. * Hemorrhagic shock * Hemoglobin \< 70 g/dL

Primary outcome measure(s)

Comparison of Blood Viscosity in Patients with ARDS and Control Group on Day 1 — At day 1
Blood viscosity will be determined after complete oxygenation of the blood, at native hematocrit, at a temperature of 25 °C. Measurements will be performed at different shear rates (11.5, 22.5, 45, 90, and 225 s-¹) using a cone-plate viscometer (Brookfield DVII+ equipped with a CPE40 cone, Brookfield Engineering Labs, Natick, MA, USA). This technique is based on applying a well-defined shear rate gradient between a moving conical surface and a fixed flat surface, with the blood sample placed between them. The fluid subjected to this shear resists flow in proportion to its viscosity. The higher the viscosity, the greater the torque required to maintain motion. This approach allows for the precise measurement of the apparent viscosity of blood across a wide range of mechanical stresses, replicating the flow conditions encountered in the bloodstream. The value at 225 s-¹ will be used as the primary endpoint (with an accuracy of 5-10 centipoise at this shear rate).

Trial sites (1)

Facility	City	Region	Status
Hopital de la Croix-Rousse	Lyon	France

More Hospices Civils de Lyon trials in France

Evaluation Patient Satisfaction After Passive Bladder Catheter Removal Compared to Active Removal Recruiting

Dance-therapy and Chronic Pain Recruiting

Immunoparalysis After Pancreaticoduodenectomy Recruiting

Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes Recruiting

Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery Recruiting

Other trials for the same condition

Effects of Ventilation With Tidal Volume Adjusted on Driving Pressure on Ventilation/Perfusion Ratios and Hemodynamics in ARDS Starting soon

Improvement of Lung and Thoracic Compliance in ARDS Patients in Prone Position by Using Inflatable Air Bag Recruiting

Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery Recruiting

V/Q Matching Variations With PEEP in ARDS According to Compliance-based Phenotypes (France) Recruiting

Speckle Tracking and Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07823296 on ClinicalTrials.gov ↗ ← All trials in France